Showing 2301-2310 of 3553 results for "".
DermwireTV — Valeant Ups Allergan Bid, Nestle Buys Injectables, and Allergan Makes Its Case
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-valeant-ups-allergan-bid-nestle-buys-injectables-and-allergan-makes-its-case/19128/BREAKING NEWS: Valeant has increased its offer for Allergan to $72 per share. Read more. Valeant sells the rights to its aesthetic injectables to Nestle, while Allergan touts physician support and challenges Valeant's business model. In this week's edition of DermWireTV, learn about Valeant's latesEffective Speechmaking for Physicians
https://practicaldermatology.com/topics/practice-management/effective-speechmaking-for-physicians/21666/Dermatologists can utilize these tips to exude confidence, make a good first impression, and connect with any audience.Filler Pearls: Refining the Art of Injection
https://practicaldermatology.com/topics/general-topics/filler-pearls-refining-the-art-of-injection/21683/Pain control is essential to treatment success with dermal fillers. Here's an update on pain management and other tactics to ensure patient comfort and optimize outcomes.Professionalism in the Workplace: Tips for Managers
https://practicaldermatology.com/topics/practice-management/professionalism-in-the-workplace-tips-for-managers/20514/Maintaining the highest possible level of professionalism can help new and seasoned managers navigate challenges and position themselves to take advantage of additional opportunities.Wet Wipe Applicators: Exploring the Future of Topical Drug Delivery
https://practicaldermatology.com/topics/psoriasis/wet-wipe-applicators-exploring-the-future-of-topical-drug-delivery/23448/The answer to convenience and adherence could be a wipe.For Now, the No Surprises Act Applies to All Providers
https://practicaldermatology.com/topics/practice-management/for-now-the-no-surprises-act-applies-to-all-providers/23780/It seems that dermatologists and others providing aesthetic services must comply with new legislation.Phase 2 and 3 Trials of JAK Inhibitors For Atopic Dermatitis: A Review
https://practicaldermatology.com/topics/atopic-dermatitis/phase-2-and-3-trials-of-jak-inhibitors-for-atopic-dermatitis-a-review/23265/A number of drugs in development show promise for one of the most challening skin diseases.Establishing Incentives for Practice Administrators
https://practicaldermatology.com/topics/practice-management/establishing-incentives-for-practice-administrators/23051/Tips to create a performance-based program that compensates appropriately and motivates the administrator to continue moving the practice forward.Taking the Pulse of Hydroquinone Therapy: A Plea for Caution
https://practicaldermatology.com/topics/general-topics/taking-the-pulse-of-hydroquinone-therapy-a-plea-for-caution/22946/Pulse therapy under physician supervision can reduce long-term exposure and help reduce the risk of untoward effects of hydroquinone therapy.Discover the Value of Lead Nurturing
https://practicaldermatology.com/topics/practice-management/discover-the-value-of-lead-nurturing/23369/How to convert leads to patients to grow your practice.